Stay updated with breaking news from David Caouette. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOTHELL - Seagen Inc. today announced data from the Phase 3 HER2CLIMB-02 clinical trial of TUKYSA in combination with the antibody-drug conjugate ado-trastuzumab emtansine . The combination showed...
BOTHELL, Wash.--(BUSINESS WIRE)--Dec 6, 2023--
– Updated Phase 2 data for ADCETRIS in combination with nivolumab in early and advanced stage classical Hodgkin lymphoma to be presented in oral session –– First preclinical data for investigational antibody-drug conjugate SGN-35C to be presented –BOTHELL, Wash.--(BUSINESS WIRE)--#ASH23--Seagen Inc. (NASDAQ: SGEN) t...
BOTHELL, Wash., & COPENHAGEN, Denmark--(BUSINESS WIRE)--Oct 22, 2023--
Media Release TIVDAK demonstrated statistically significant overall survival, progression-free survival and objective response rate compared to...